Entrada Therapeutics
TRDA
#6909
Rank
HK$3.80 B
Marketcap
HK$101.61
Share price
0.54%
Change (1 day)
-4.61%
Change (1 year)

Revenue for Entrada Therapeutics (TRDA)

Revenue in 2024 (TTM): HK$1.68 Billion

According to Entrada Therapeutics's latest financial reports the company's current revenue (TTM ) is HK$1.67 Billion. In 2023 the company made a revenue of HK$1.00 Billion an increase over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Entrada Therapeutics from 2021 to 2024

20222023$0.5B$1B$1.5B$2B0companiesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) HK$1.68 B66.85%
2023 HK$1.00 B
2022 N/A
2021 N/A